BlackRock announced updates to the managed dividend plans for BMEZ, BSTZ, and BTX

BlackRock Health Sciences Term Trust Releases Update on Managed Distribution Plan

BlackRock Health Sciences Term Trust (BMEZ) has updated its managed distribution plan, effective October 2025. The Trust will shift from a floating rate to a level rate distribution to enhance stability and potentially grow net asset value. New monthly distribution rates are $0.11000 for BMEZ, $0.16250 for BlackRock Science and Technology Term Trust (BSTZ), and $0.05250 for BlackRock Technology and Private Equity Term Trust (BTX). These changes aim to effectively manage public and private investments.

BlackRock Health Sciences Trust Releases Report on Fund Distributions

BlackRock Health Sciences Trust (NYSE: BMEZ) has announced its monthly distribution plan, maintaining a level distribution of income, capital gains, and/or return of capital. The fund's managed distribution plan supports a monthly distribution based on an annual rate of 12% of the fund’s 12-month rolling average daily net asset value, calculated from July 25, 2024, to July 24, 2025. This strategy aims to provide consistent income for shareholders.

BlackRock Health Sciences Term Trust (BMEZ) Announces Final Results of Tender Offer | BMEZ Stock News

BlackRock Health Sciences Term Trust (BMEZ) announced the final results of its tender offer for up to 40% of its outstanding common shares, which expired on April 17, 2025. The offer was undersubscribed, and the Fund will purchase all properly tendered shares. Payment for accepted shares is expected by April 25, 2025. The purchase price is set at $14.2086, equating to 99.5% of the Fund’s net asset value per share as of April 21, 2025.

BlackRock Health Sciences Term Trust (BMEZ) Announces Expiration and Preliminary Results of Tender Offer | BMEZ Stock News

BlackRock Health Sciences Term Trust (BMEZ) announced the expiration and preliminary results of its tender offer for up to 40% of its outstanding common shares. The tender offer, which began on March 21, 2025, was undersubscribed, with 38,753,713 shares tendered. Shareholders who properly tendered their shares will receive 99.5% of the Fund's net asset value as of April 21, 2025. Final results are expected to be announced around the same date.